Clancy Paul J
- SEC CIK
- 0001409601
In the past year, 1 open-market sale filing worth $1.42M and no purchases.
Current role at each company
- INCY Incyte CorpDirectoras of Jul 2, 2026
- SION Sionna Therapeutics, Inc.Directoras of Jun 18, 2026
- EXAS Exact Sciences CorpDirectoras of Mar 23, 2026
- XLO Xilio Therapeutics, Inc.Directoras of Jun 12, 2025
- AGIO Agios Pharmaceuticals, Inc.Directoras of Jun 23, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.42M
- 1 filing
- Net
- −$1.42M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Clancy Paul J as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
INCY Incyte Corp
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 21, 2026 (view filing) | May 19 | 2 days | Clancy Paul JDirector | SSale | −15.0K | $94.93 | −$1.42M | −38.7%23.7K after | 10b5-1 |